A Budget Impact Model Estimating the Financial Impact of Increased Use of Generic Bortezomib Intravenous (Iv) in the Treatment of Relapsed/Refractory Multiple Myeloma (Mm) in Venezuela
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.245
https://www.valueinhealthjournal.com/article/S1098-3015(15)02321-9/fulltext
Title :
A Budget Impact Model Estimating the Financial Impact of Increased Use of Generic Bortezomib Intravenous (Iv) in the Treatment of Relapsed/Refractory Multiple Myeloma (Mm) in Venezuela
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02321-9&doi=10.1016/j.jval.2015.09.245
First page :
A818
Section Title :
Research Podium Presentations - Session 1
Open access? :
No
Section Order :
2469